Cancer is one of the most serious diseases that are harmful to human health. Systemic chemotherapy is an optimal therapeutic strategy for the treatment of cancer, but great difficulty has been encountered in its administration in the form of multidrug resistance (MDR). As an enzyme on the outer cell surface, CD13 is documented to be involved in the MDR development of tumor cells. In this review, we will focus on the role of CD13 in MDR generation based on the current evidence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751223 | PMC |
| http://dx.doi.org/10.3727/096504020X15919605976853 | DOI Listing |
Publication Analysis
Top Keywords
multidrug resistance
8
cd13 key
4
key player
4
player multidrug
4
resistance cancer
4
cancer chemotherapy
4
chemotherapy cancer
4
cancer serious
4
serious diseases
4
diseases harmful
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!